Kilitch Drugs(I) Ltd.

NSE: KILITCH | BSE: 524500

Mid-range Performer

Download real time

353.15 7.90 (2.29%)

23,269 NSE+BSE Volume

High volume today

NSE 20 Mar, 2025 3:31 PM (IST)

567.9

Market Cap

Above industry Median

0.7

Beta 1Year

Very Low volatility

Kilitch Drugs(I) Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Kilitch Drugs(I) Ltd. from all sources in a single place.

Load latest

Kilitch Drugs(I) Ltd.

09 Dec 2024

353.15

2.29%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

We hereby inform you that the Company has received intimation from the registrar and share transfer agent to issue duplicate share certificate

Kilitch Drugs(I) Ltd.

14 Nov 2024

353.15

2.29%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of copy of Newspaper publication of extract of financial results for the quarter ended 30th September, 2024 to stock exchanges

Kilitch Drugs(I) Ltd.

12 Nov 2024

353.15

2.29%

Board Meeting

KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Submission Of Outcome Of Board …

BSE India

Submitting herewith the outcome of board meeting for approval of unaudited financial results for the quarter ended 30.09.2024

Kilitch Drugs(I) Ltd.

12 Nov 2024

353.15

2.29%

Result

KILITCH DRUGS (INDIA) LTD. - 524500 - Financial Results For The Quarter Ended 30Th September, 2024

BSE India

We are submitting herewith the financial results for the quarter ended 30th September, 2024

Kilitch Drugs(I) Ltd.

11 Nov 2024

353.15

2.29%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Regulation 39(3) of SEBI LODR Regulations, 2015, we hereby intimate the issue of Duplicate share certificate to one of the shareholders due to loss of share certificate by him

Kilitch Drugs(I) Ltd.

04 Nov 2024

353.15

2.29%

Board Meeting

KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for To Consider And Approve The …

BSE India

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th September, 2024

Kilitch Drugs(I) Ltd.

22 Oct 2024

353.15

2.29%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation Of Loss of share certificate by Mr. Ved Bhushan received from Company to stock exchanges

Kilitch Drugs(I) Ltd.

19 Oct 2024, 05:31PM

353.15

2.29%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation of Issue of Duplicate Share Certificate under regulation 39(3) of the listing regulation to the stock exchange

Kilitch Drugs(I) Ltd.

09 Oct 2024

353.15

2.29%

Company Update

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

We are submitting herewith the copy of certificate received from Registrar and Share Transfer Agent of the Company under Regulation 74(5) of SEBI (DP) Regulation, 2018

Kilitch Drugs(I) Ltd.

07 Oct 2024

353.15

2.29%

Corp. Note

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Issue of Duplicate Share Certificate to Mr. Vishwa Jit Sharma due to loss of original share certificate by him

No results found

Is Kilitch Drugs(I) Ltd. worth buying?

41 Votes:

Buy 85.37%

Sell 12.2%

Hold 2.44%